Document is current
Any future updates will be listed below
-
Authors
Piergiovanni, Monica https://orcid.org/0000-0003-4992-2068
Mennecozzi, Milena
Barale-Thomas, Erio
Danovi, Davide https://orcid.org/0000-0003-4119-5337
Dunst, Sebastian
Egan, David
Fassi, Aurora
Hartley, Matthew
Kainz, Philipp
Koch, Katharina
Le Dévédec, Sylvia E. https://orcid.org/0000-0002-0615-9616
Mangas, Iris
Miranda, Elena
Nyffeler, Jo
Pesenti, Enrico
Ricci, Fernanda
Schmied, Christopher
Schreiner, Alexander
Stokar-Regenscheit, Nadine
Swedlow, Jason R.
Uhlmann, Virginie
Wieland, Fredrik C.
Wilson, Amy
Whelan, Maurice
- License Information
-
More Information
Article History
Received: 15 October 2024
Accepted: 26 November 2024
First Online: 13 February 2025
Declarations
:
: Erio Barale-Thomas, David Egan, Katharina Koch, Elena Miranda, Enrico Pesenti, Fernanda Ricci, Alexander Schreiner, Nadine Stokar-Regenscheit, Fredrik C. Wieland and Amy Wilson are employed by the respective companies. Elena Miranda holds shares in GSK. Amy Wilson holds shares in AstraZeneca. Nadine Stokar-Regenscheit holds share in F.Hoffmann-La Roche Ldt. Katharina Koch holds share in DNTOX. Philipp Kainz is a director and shareholder of KOLAIDO GmbH. David Egan is a director and shareholder of Core Life Analytics BV. Iris Mangas contributed in particular to the section “” of this publication. The views expressed, and arguments employed in this article are those of the authors and do not necessarily reflect the official views or policies of their companies or institutions of employment or of the governments of its member countries.
